A test base is any compound used alongside SARMs to maintain testosterone levels while your natural production drops. SARMs activate androgen receptors in muscle and bone, but this signals your brain to slow down or stop making its own testosterone. Without some form of testosterone support, users often experience fatigue, low libido, mood changes, and loss of the results they’re working toward. A test base prevents that crash.
Why SARMs Suppress Testosterone
Your body regulates testosterone through a feedback loop between the brain and the testes. The hypothalamus releases a signaling hormone, which tells the pituitary gland to produce LH (luteinizing hormone) and FSH (follicle-stimulating hormone). These two hormones then tell the testes to make testosterone. When your brain detects enough androgenic activity, whether from your own testosterone or from a SARM binding to androgen receptors, it dials back LH and FSH. Less signaling means less natural testosterone.
Clinical data on LGD-4033 showed dose-dependent suppression of total testosterone, free testosterone, and sex hormone-binding globulin within just 21 days. Even at doses as low as 1 mg per day, free testosterone was significantly suppressed. The stronger the SARM and the longer the cycle, the deeper the suppression tends to go.
The Estrogen Problem Most People Miss
Testosterone doesn’t just build muscle. Your body converts a portion of it into estrogen through a process called aromatization. Estrogen plays a critical role in joint health, mood stability, cardiovascular function, and even libido in men. SARMs do not aromatize. They cannot convert into estrogen. So when a SARM suppresses your natural testosterone, your estrogen levels drop along with it, and nothing replaces that estrogen.
This is why many SARM users report dry, achy joints, brain fog, irritability, and a sharp decline in sex drive mid-cycle. These symptoms are often signs of low estrogen rather than low testosterone. A test base that includes actual testosterone (which does aromatize) can help maintain healthy estrogen levels during the cycle.
Symptoms of Running SARMs Without a Base
The symptoms of hormonal suppression range from mildly annoying to seriously disruptive. The most commonly reported issues include low libido or erectile dysfunction, persistent fatigue, depressed mood, increased anxiety, difficulty concentrating, and loss of motivation. Research on recovery from androgen-induced suppression found that 40% of affected men reported low libido compared to 10% in controls, and 27% experienced erectile dysfunction compared to 7%. Depression rates were roughly two to three times higher than in men who had never suppressed their hormones.
These symptoms can appear within a few weeks of starting a cycle, especially with more potent SARMs. They also tend to linger after the cycle ends, sometimes for months, particularly if no recovery protocol is used.
Common Test Base Options
There are three main approaches people use as a test base during a SARM cycle, each with a different mechanism and risk profile.
Injectable Testosterone
This is the most straightforward option: replacing the testosterone your body stops making with an external source. Testosterone cypionate and enanthate are the most common forms. The goal is to maintain levels in the normal physiological range, generally 400 to 700 ng/dL, using what would be considered a TRT (testosterone replacement therapy) dose. The FDA’s recommended range for treating low testosterone is 50 to 400 mg injected every two to four weeks, though most people using it as a SARM base aim for the lower end to simply maintain normal function rather than push levels higher.
The advantage is reliability. Injectable testosterone aromatizes, so it supports estrogen levels alongside androgen levels. The downside is significant: injecting exogenous testosterone fully shuts down your natural production. Your body stops making its own testosterone entirely because it detects more than enough in the bloodstream. That means you will need post-cycle therapy afterward, and recovery of natural production can take weeks to months. Testosterone use also raises hemoglobin and hematocrit levels (thickening the blood), with treated men roughly three times more likely to develop erythrocytosis than untreated men. It also lowers HDL (“good”) cholesterol and, at higher doses, raises LDL cholesterol.
Enclomiphene
Enclomiphene is a selective estrogen receptor modulator (SERM) that works by a completely different mechanism. Instead of replacing testosterone from outside, it tricks your brain into making more of its own. It blocks estrogen receptors in the hypothalamus, which prevents the brain from detecting estrogen and triggering the “slow down” signal. The result is increased LH and FSH output, which stimulates the testes to produce more testosterone.
Clinical studies found that enclomiphene consistently raised total testosterone into the normal range while pushing LH and FSH above normal levels. The 25 mg dose produced significantly greater LH increases than lower doses. Importantly, the testosterone-elevating effect persisted for at least one week after stopping the drug, because LH levels remained elevated.
This is why enclomiphene has become popular in the SARM community. It keeps the natural production pathway active rather than shutting it down, which theoretically makes post-cycle recovery faster and easier. It also doesn’t carry the blood-thickening or cholesterol risks of injectable testosterone. The tradeoff is that it doesn’t directly provide estrogen support the way testosterone does, since it works by blocking estrogen signaling in the brain. Some users report that it can push estrogen-related side effects in unpredictable directions.
4-Andro (4-DHEA)
4-Andro is a prohormone, a precursor compound that your body converts into testosterone after you take it. It’s sold as a supplement and taken orally, which makes it the most accessible option. Because it converts to actual testosterone, it can aromatize into estrogen, providing some of the hormonal balance that straight SARMs lack. However, like injectable testosterone, it introduces an external androgen source, meaning it will still contribute to suppression of your natural production. The conversion rate is also inefficient, so the actual testosterone yield per dose is lower and less predictable than a direct injection.
Test Base vs. Post-Cycle Therapy
These are two different tools that address different phases. A test base is used during the cycle to prevent suppression symptoms while the SARM is active. Post-cycle therapy (PCT) is used after the cycle to help restart natural testosterone production once all compounds have cleared your system.
Using a SERM like enclomiphene blurs this line somewhat. Because it stimulates natural production rather than replacing it, some users run it during the cycle as a base and continue it afterward as PCT, tapering the dose down. With injectable testosterone as a base, PCT becomes more necessary, not less, because your natural production will be fully shut down by the end of the cycle. Research on exogenous testosterone shows that LH and FSH can become undetectable within two weeks of starting moderate doses and may take weeks after cessation to return.
The key distinction: a test base keeps you feeling functional during the cycle. PCT determines how quickly and completely you recover afterward. They solve different problems, and one does not eliminate the need for the other, especially when the base itself is suppressive.
Choosing the Right Approach
The choice depends largely on what tradeoffs you’re willing to accept. Injectable testosterone is the most effective at maintaining both androgen and estrogen levels, but it guarantees full shutdown and adds its own health risks. Enclomiphene preserves natural production and is easier to recover from, but the hormonal picture is less clean since you’re fighting suppression and stimulation at the same time. 4-Andro is the most convenient but the least predictable in terms of actual testosterone delivery.
What every option has in common is that none of them make SARMs “safe.” SARMs themselves are not approved for human use, and the long-term effects of combining them with any test base compound are not studied in clinical settings. The suppression data that exists comes from short-term trials, and recovery timelines vary widely between individuals. Fatigue and depressive symptoms after cycles can persist for months, and some research suggests that quality-of-life measures may not fully return to pre-use levels even years later.